HeartFlow Analysis vs VX1+
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, AI-powered solution for the diagnosis and management of coronary artery disease (CAD). It is ideal for creating personalized 3D models of coronary arteries from standard CT scans, providing detailed FFRct and plaque analysis to inform treatment strategies before any invasive intervention.
View HeartFlow Analysis →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and need real-time, AI-driven guidance. This tool is specifically designed to assist in the immediate identification of abnormal electrograms during the procedure, enhancing the precision and potential success of the ablation.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | VX1+ |
|---|---|---|
| Pricing | Contact vendor for pricing | Unknown |
| Deployment | Cloud-based (AWS) | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VX1+Tool B (VX1+) offers a 'Simple user interface with color coding' for real-time assistance during complex cardiac ablation procedures, directly aiding electrophysiologists in a high-stress environment. Tool A (HeartFlow Analysis), while seamlessly integrated into a clinical workflow, primarily provides post-scan analysis via a web interface, making its usability more about interpretation rather than immediate, interactive procedural guidance.
Clinical Value
HeartFlow AnalysisTool A (HeartFlow Analysis) has extensive clinical validation, including multiple large-scale trials demonstrating high diagnostic accuracy, reduction in unnecessary invasive procedures, and cost savings, backed by ACC/AHA guidelines and over 600 peer-reviewed publications. While Tool B (VX1+) shows promising initial results for improving ablation outcomes, its FDA clearance explicitly states that its clinical significance for catheter ablation outcomes 'has not been established by clinical investigations'.
Pricing & Value
HeartFlow AnalysisTool A (HeartFlow Analysis) has a clear and established value proposition with Category I CPT codes for its analyses, widespread coverage by Medicare and most U.S. commercial payers, and proven cost-effectiveness. Tool B (VX1+) lacks publicly available pricing details and established reimbursement pathways, making its financial value less transparent for potential adopters.
Enterprise Readiness
HeartFlow AnalysisTool A (HeartFlow Analysis) explicitly states HIPAA compliance, BAA availability, FDA clearance, and adherence to robust security certifications like HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001, with cloud-based deployment on AWS. While Tool B (VX1+) integrates with existing EP systems and states a commitment to compliance, it does not explicitly confirm BAA or HIPAA in the provided facts, making HeartFlow's readiness more definitively documented.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. Tool A (HeartFlow Analysis) pioneered non-invasive FFRct, fundamentally changing CAD diagnosis and continuing to innovate with plaque analysis. Tool B (VX1+) is groundbreaking as the first FDA-cleared AI for real-time guidance during interventional electrophysiology procedures, offering a novel approach to improving ablation outcomes.
Support & Docs
HeartFlow AnalysisTool A (HeartFlow Analysis) provides comprehensive support, including hands-on training, technology integration, expert coding and reimbursement assistance, educational materials, peer mentorship, and dedicated clinical and technical support teams. While Tool B (VX1+) mentions a user manual and brochure, HeartFlow's documented support offerings are far more extensive and clearly articulated.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | VX1+ |
|---|---|---|
| Name | HeartFlow Analysis | VX1+ |
| Company | HeartFlow | Volta Medical |
| Primary Use Case | Non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Target Specialties | Cardiology, Radiology | Cardiology |
| Core AI Functionality | AI-powered 3D modeling of coronary arteries; Computational Fluid Dynamics (CFD) for blood flow simulation. | AI-powered real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures. |
| Specific Analytical Output | Fractional Flow Reserve derived from CT (FFRct) analysis; Plaque Analysis (quantification and characterization); Roadmapu2122 Analysis for CCTA reading. | AI-driven insights to assist electrophysiologists during ablation procedures; Simple user interface with color coding for electrogram dispersion (blue, orange, red); Provides cycle length estimation from electrograms. |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and VX1+.